CoChat
Sign Up
PreprintCited by 153Computational Drug Discovery MethodsMachine Learning in BioinformaticsMachine Learning in Materials Science

Atomic convolutional networks for predicting protein-ligand binding affinity

Open access
Gomes, Joseph, Ramsundar, Bharath, Feinberg, Evan N., Pande, Vijay S.·2017·arXiv
DOI 10.48550/arxiv.1703.10603arXiv 1703.10603
Open this paper in CoChat — free accountOpen PDF

Abstract

Empirical scoring functions based on either molecular force fields or cheminformatics descriptors are widely used, in conjunction with molecular docking, during the early stages of drug discovery to predict potency and binding affinity of a drug-like molecule to a given target. These models require expert-level knowledge of physical chemistry and biology to be encoded as hand-tuned parameters or features rather than allowing the underlying model to select features in a data-driven procedure. Here, we develop a general 3-dimensional spatial convolution operation for learning atomic-level chemical interactions directly from atomic coordinates and demonstrate its application to structure-based bioactivity prediction. The atomic convolutional neural network is trained to predict the experimentally determined binding affinity of a protein-ligand complex by direct calculation of the energy associated with the complex, protein, and ligand given the crystal structure of the binding pose. Non-covalent interactions present in the complex that are absent in the protein-ligand sub-structures are identified and the model learns the interaction strength associated with these features. We test our model by predicting the binding free energy of a subset of protein-ligand complexes found in the PDBBind dataset and compare with state-of-the-art cheminformatics and machine learning-based approaches. We find that all methods achieve experimental accuracy and that atomic convolutional networks either outperform or perform competitively with the cheminformatics based methods. Unlike all previous protein-ligand prediction systems, atomic convolutional networks are end-to-end and fully-differentiable. They represent a new data-driven, physics-based deep learning model paradigm that offers a strong foundation for future improvements in structure-based bioactivity prediction.

Integrity signals

Registry

DataCite · 10.48550/arxiv.1703.10603

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AI modeling paradigms have been used successfully in the biomolecular realm, for example, to predict 3D molecular structures from sequences and interactions between different molecular components.

    “Such modeling paradigms have been used successfully in the biomolecular realm, for example, to predict three-dimensional (3D) molecular structures from sequences32–34 and interactions between different molecular components.35–38”

    From How to build the virtual cell with artificial intelligence: Priorities and opportunities (2024) · cites this paper as [35]

Cites

Flagged first, then by citations

1 of the 28 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Related

Authors
Gomes, J., Ramsundar, B., Feinberg, E. N., & Pande, V. S.
Affiliations
  • Stanford University (US)
  • Stanford Medicine (US)
ORCID
Venue
arXiv
Publisher
arXiv
Published
2017
ISSN
2331-8422 (ISSN-L)
DOI
10.48550/arxiv.1703.10603
arXiv
1703.10603
OpenAlex
W2604306554
Cited by
150
References
28
Citations by year
2026: 2 · 2025: 13 · 2024: 8 · 2023: 13 · 2022: 14 · 2021: 25 · 2020: 25 · 2019: 24 · 2018: 20 · 2017: 6
Type
posted content
Language
en
Open access
Licence
arxiv.org/licenses/nonexclusive-distrib/1.0/
Locations
  • arXiv (Cornell University) (submittedVersion)
  • arXiv (Cornell University)
Funders
National Institutes of Health
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
  • Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
Keywords
protein-ligand binding affinity prediction, binding free energy, structure-based drug design, non-covalent interactions, spatial convolution, PDBbind

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review